Ajooni Biotech Peer Comparison
NSE: AJOONI
₹3.00
As on 19-Nov-2026 10:29IST
Market cap
₹54 Cr
Revenue (TTM)
₹246 Cr
P/E Ratio
12.8
P/B Ratio
0.6
Div. Yield
0 %
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
54 | 11,347 | 543 | 87 | 47 |
Revenue (₹ Cr) |
246 | 10,901 | 1,757 | 98 | 1 |
Net Profit (₹ Cr) |
4.24 | 400.49 | 12.33 | 3.13 | -0.09 |
Net Margin (%) |
1.71 | 3.63 | 0.70 | 3.15 | -9.45 |
RoE (%) |
4.58 | 24.08 | 3.55 | 5.20 | -0.35 |
Price to Earnings |
12.78 | 24.18 | 44.00 | 27.89 | -- |
Price-To-Book |
0.58 | 5.47 | 1.67 | 1.43 | 1.53 |
Income Statement (₹ Cr)
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Operating Revenue
|
246.37 | 10,901.17 | 1,756.92 | 98.12 | 0.54 |
|
Total Income
|
247.59 | 11,023.92 | 1,769.99 | 99.32 | 0.90 |
|
Total Expenditure
|
236.61 | 10,080.79 | 1,741.04 | 94.07 | 0.86 |
|
EBITDA
|
9.76 | 820.38 | 15.87 | 4.05 | -0.33 |
|
Depreciation
|
3.35 | 228.33 | 8.02 | 0.22 | 0.00 |
|
EBIT
|
6.41 | 592.05 | 7.86 | 3.83 | -0.33 |
|
Interest
|
1.56 | 126.12 | 2.64 | 0.75 | 0.00 |
|
Other Income
|
1.23 | 122.75 | 13.07 | 1.20 | 0.36 |
|
Exceptional Items
|
0.00 | -30.44 | 0.47 | 0.00 | 0.00 |
|
Profit before Tax
|
6.08 | 558.24 | 18.76 | 4.28 | 0.03 |
|
Provision for Tax
|
1.84 | 157.75 | 6.43 | 1.15 | 0.12 |
|
Profit after Tax
|
4.24 | 400.49 | 12.33 | 3.13 | -0.09 |
Liabilities (₹ Cr)
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
93.88 | 2,075.88 | 324.96 | 61.07 | 33.08 |
|
Minority Interest
|
0.00 | 26.31 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
6.82 | 577.23 | 18.25 | 0.77 | 0.00 |
|
Current Liabilities
|
31.49 | 3,654.87 | 48.11 | 12.77 | 0.21 |
|
Total Liabilities
|
120.37 | 6,160.85 | 414.98 | 72.25 | 15.61 |
Assets (₹ Cr)
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
36.14 | 2,899.41 | 66.97 | 12.02 | 0.15 |
|
Current Assets
|
78.23 | 3,022.63 | 321.99 | 62.02 | 33.14 |
|
Total Assets
|
120.37 | 6,160.85 | 414.98 | 72.25 | 15.61 |
|
Total Debt*
|
17.76 | 1,468.43 | 24.87 | 10.10 | 0.00 |
|
Net Current Assets
|
46.74 | -632.24 | 273.87 | 49.25 | 32.93 |
|
Contingent Liabilities
|
-- | 164.76 | 1.86 | 0.05 | -- |
Cashflow (₹ Cr)
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-5.73 | 1,281.17 | 53.52 | -1.30 | 0.00 |
|
Cash Flow from Investing Activities
|
-15.77 | -150.39 | -8.92 | -2.95 | -- |
|
Cash from Financing Activities
|
15.09 | -868.90 | -33.22 | -0.18 | 0.00 |
|
Net Cash Inflow / Outflow
|
-6.41 | 261.88 | 11.38 | -4.43 | 0.00 |
Ratios
Profitability Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
ROCE (%)
|
6.53 | 20.95 | 33.62 | 8.94 | 2.84 |
|
ROE (%)
|
4.58 | 24.08 | 3.55 | 5.20 | -0.35 |
|
ROA (%)
|
3.59 | 6.39 | 3.00 | 4.31 | -0.51 |
|
EBIT Margin (%)
|
2.60 | 5.43 | 0.45 | 3.90 | -61.27 |
|
Net Margin (%)
|
1.71 | 3.63 | 0.70 | 3.15 | -9.45 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
95.05 | 11.64 | 6.66 | 48.29 | -77.37 |
|
EBIT Growth (%)
|
110.10 | -4.77 | -95.08 | -11.20 | -159.49 |
|
Net Profit Growth (%)
|
6.32 | 11.14 | -90.31 | -18.10 | -114.03 |
|
EPS Growth (%)
|
5.68 | 13.56 | -98.77 | -25.49 | -129.45 |
|
Book Value Growth (%)
|
3.69 | -14.87 | 17.78 | 6.21 | 2.11 |
Valuation Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Price / Earnings
|
12.22 | 22.94 | 45.26 | 15.33 | -117.23 |
|
Price / Book Value
|
0.58 | 5.47 | 1.67 | 1.43 | 1.53 |
|
Dividend Yield (%)
|
0.00 | 1.87 | 7.37 | 0.00 | 0.00 |
|
EV/EBITDA
|
7.33 | 15.24 | 23.81 | 21.51 | -143.79 |
|
Market Cap (₹ Cr)
|
66.15 | 10,276.68 | 564.14 | 115.67 | 15.29 |
Solvency Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.07 | 0.16 | 0.05 | 0.01 | 0.00 |
|
Short term debt to equity ratio
|
0.18 | 0.19 | 0.00 | 0.15 | -- |
|
Current Ratio
|
2.48 | 0.83 | 6.69 | 4.86 | 157.07 |
|
Quick Ratio
|
1.52 | 0.33 | 3.41 | 3.89 | 124.98 |
|
Interest Coverage
|
4.90 | 5.43 | 8.12 | 6.73 | 131.18 |
Operating Efficiency Ratios
| Ajooni Biotech | Godrej Agrovet | KSE | Narmada Agrobase | Prism Medico | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
9.01 | 6.86 | 0.47 | 37.78 | 730.91 |
|
Asset Turnover
|
2.09 | 1.74 | 4.28 | 1.35 | 0.03 |
|
Receivable days
|
34.07 | 21.15 | 0.29 | 126.71 | 561.48 |
|
Inventory Days
|
63.48 | 44.46 | 27.72 | 87.41 | 1,011.41 |
|
Payable days
|
15.31 | 31.76 | 2.46 | 3.90 | 28.80 |
|
Cash Conversion Cycle
|
82.25 | 33.86 | 25.54 | 210.22 | 1,544.08 |